Carbon monoxide: From toxin to endogenous modulator of cardiovascular functions

Brazilian Journal of Medical and Biological Research

Volumn 32, Issue 1, 1999, Pages 1-14

  Johnson, R A ^a   Kozma, F ^b   Colombari, E ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

Author keywords

Blood pressure; Carbon monoxide; Central nervous system; Heme; Heme oxygenase; Vascular tone

Indexed keywords

MAMMALIA;

CARBON MONOXIDE; HEME; HEME OXYGENASE;

BLOOD PRESSURE; CARDIOVASCULAR FUNCTION; HUMAN; PHYSIOLOGY; REVIEW; SOLITARY TRACT NUCLEUS; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; VASODILATATION;

BLOOD PRESSURE; CARBON MONOXIDE; CARDIOVASCULAR PHYSIOLOGY; HEME; HEME OXYGENASE (DECYCLIZING); HUMANS; MUSCLE, SMOOTH, VASCULAR; SOLITARY NUCLEUS; VASOCONSTRICTION; VASODILATION;

EID: 0032602310     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X1999000100001     Document Type: Article

References (57)

1. Penney DG (1988). A revew: Hemodynamic response to carbon monoxide. Environmental Health Perspectives, 77: 121-130.
2. Penny DG (1996). Carbon Monoxide. 1st edn. CRC Press, Inc., New York.
3. Tenhunen R, Marver HS & Schmid R (1969). Microsomal heme oxygenase Journal of Biological Chemistry, 244: 6388-6394.
4. Marks GS, Brien JF, Nakatsu K & McLaughlin BE (1991). Does carbon monoxide have a physiological function? Trends in Pharmacological Sciences, 12: 185-188.
5. Raub JA & McMullen TB (1991). Air Quality Criteria for Carbon Monoxide. 1st edn. United States Environmental Protection Agency, Washington, DC.
6. Penney DG (1990) Acute carbon monoxide poisoning: animal models: a review Toxicology, 62: 123-160.
7. White KA & Marletta MA (1992). Nitric oxide synthase is a cytochrome P-450 type hemoprotein. Biochemistry, 31: 6627-6631.
8. Schmidt HHHW (1992). NO, CO and HO endogenous soluble guanylyl cyclase-activating factors. FEBS Letters, 307: 102-107.
9. Raff H & Jankowski B (1994). Inhibition of aldosterone release by hypoxia in vitro: interaction with carbon monoxide. Journal of Applied Physiology, 76: 689-693.
10. Wada A, Ohnishi T, Nonaka Y, Okamoto M & Yamano T (1985). Synthesis of aldosterone by a reconstituted system of cytochrome P-45011 beta from bovine adrenocortical mitochondria. Journal of Biochemistry, 98: 245-256.
11. Graser T, Vedernikov YP & Li DS (1990). Study on the mechanism of carbon monoxide induced endothelium-independent relaxation in porcine coronary artery and vein. Biochimica et Biophysica Acta, 49: 293-296.
12. Kozma F, Johnson RA, Tong X & Nasjletti A (1998). Role of endogenous carbon monoxide in the regulation of basal tone in resistance vessels. Hypertension, 32: 60 (Abstract).
13. Coceani F, Kelsey L & Seidlitz E (1996). Carbon monoxide-induced relaxation of the ductus artenosus in the lamb: evidence against the prime role of guanylyl cyclase. British Journal of Pharmacology, 118: 1689-1696.
14. Gaspard S, Chottard G, Mahy JP & Mansuy D (1996) Study of the coordination chemistry of prostaglandin G/H synthase by resonance Raman spectroscopy. European Journal of Biochemistry, 238: 529-537
15. Hu S & Kincaid JR (1992). Resonance Raman studies of the carbonmonoxy form of catalase. Evidence for and effects of phenolate ligation FEBS Letters, 314: 293-296.
16. Wang R, Wu L & Wang Z (1997). The direct effect of carbon monoxide on KCa channels in vascular smooth muscle cells. Pfluegers Archives, 434: 285-291.
17. Percival MD, Ouellet M, Vincent CJ, Yergey JA, Kennedy BP & O'Neill GP (1994). Purification and characterization of recombinant human cyclooxygenase-2. Archives of Biochemistry and Biophysics, 315: 111-118.
18. Kutty RK & Maines MD (1984). Hepatic heme metabolism: Possible role of biliverdin in the regulation of heme oxygenase activity. Biochemical and Biophysical Research Communications, 122: 40-46.
19. Cook MN, Nakatsu K, Marks GS, McLaughlin BE, Vreman HJ, Stevenson DK & Brien JF (1995). Heme oxygenase activity in adult rat aorta and liver as measured by carbon monoxide formation. Canadian Journal of Physiology and Pharmacology, 73: 515-518.
20. McCoubrey Jr WK, Huang TJ & Maines MD (1997). Isolation and characterization of a cDNA from the rat brain that encodes hemeprotein heme oxygenase-3. European Journal of Biochemistry, 247: 725-732.
21. Maiones MD (1997). The heme oxygenase system: A regulator of second messenger classes. Annual Reviews in Pharmacology and Toxicology, 37: 517-554.
22. McCoubrey Jr WK, Eke B & Maines MD (1995). Multiple transcripts encoding heme oxygenase-2 in rat testis: developmental and cell-specific regulation of transcripts and protein. Biology of Reproduction, 53: 1330-1338.
23. Johnson RA, Lavesa M, DeSeyn K, Scholer MJ & Nasjletti A (1996). Heme oxygenase substrates acutely lower blood pressure in hypertensive rats. American Journal of Physiology, 271: H1132-H1138.
24. Moore MR, McColl KEL, Rimington C & Goldberg A (1987). Disorders of Porphyrin Metabolism. Plenum Press, New York.
25. Falk JE (1964). Porphyrins and Metalloporphyrins. Elsevier Publishing Company, Amsterdam, Holland.
26. Tenhunen R (1972). Method for micoassay of microsomal heme oxygenase activity. Analytical Biochemistry, 45: 600-607.
27. Vreman HJ, Lee OK & Stevenson DK (1991). In vitro and in vivo characteristics of a heme oxygenase inhibitor: ZnBG. American Journal of the Medical Sciences, 302: 335-341.
28. Wolff DG & Bidlack WR (1976). The formation of carbon monoxide during peroxidation of microsomal lipids. Biochemical and Biophysical Research Communications, 73: 850-857.
29. Moncada S & Higgs EA (1995). Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB Journal, 9: 1319-1330.
30. Maines MD (1988). Heme oxygenase: function, multiplicity, regulatory mechanisms, and clinical applications. FASEB Journal, 2: 2557-2568.
31. Sacerdoti D, Escalante B, Abraham NG, McGiff JC, Levere RD & Schwartzman ML (1989). Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats. Science, 243: 388-390.
32. Tenhunen R, Tokola O & Linden IB (1987). Haem arginate: a new stable haem compound. Journal of Pharmacy and Pharmacology, 39: 780-786.
33. Linden I-B, Tokola O, Karlsson M & Tenhunen R (1987). Fate of heme after parenteral administration of heme arginate to rabbits. Journal of Pharmacy and Pharmacology, 39: 96-102.
34. Vallier HA, Rodgers PA & Stevenson DK (1993). Inhibition of heme oxygenase after oral vs intraperitoneal administration of chromium porphyrins. Life Sciences, 52: 79-84.
35. Vreman HJ, Ekstrand BC & Stevenson DK (1993). Selection of metalloporphyrin herne oxygenase inhibitors based on potency and photoreactivity. Pediatric Research, 33: 195-200.
36. Ignarro LJ, Wood KS & Wolin MS (1984). Regulation of purified soluble guanylate cyclase by porphyrins and metalloporphyrins: a unifying concept. Advances in Cyclic Nucleotide and Protein Phosphorylation Research, 17: 267-274.
37. Grundemar L & Ny L (1997). Pitfalls in using metalloporphyrins in carbon monoxide research. Trends in Pharmacological Sciences, 18: 193-195.
38. Kanten WE, Penney DG, Francisco K & Thill JE (1983). Hemodynamic response to acute carboxyhemoglobinemia in the rat. American Journal of Physiology, 244: H320-H327.
39. Levere RD, Martasek P, Escalante B, Schwartzman ML & Abraham NG (1990). Effect of heme arginate administration on blood pressure in spontaneously hypertensive rats. Journal of Clinical Investigation, 86: 213-219.
40. Johnson RA, Lavesa M, Askari B, Abraham NG & Nasjletti A (1995). A heme oxygenase product, presumably carbon monoxide, mediates a vasodepressor role in rats. Hypertension, 25: 166-169.
41. Verma A, Hirsch DJ, Glatt CE, Ronnett GV & Snyder SH (1993). Carbon monoxide: A putative neural messenger. Science, 259: 381-384.
42. Zakhary R, Gaine SP, Dinerman JL, Ruat M, Flavahan NA & Snyder SH (1996). Heme oxygenase 2: endothelial and neuronal localization and role in endothelium-dependent relaxation. Proceedings of the National Academy of Sciences, USA, 93: 795-798.
43. Johnson RA, Colombari E, Colombari DSA, Lavesa M, Talman WT & Nasjletti A (1997). Role of endogenous carbon monoxide in central regulation of arterial pressure. Hypertension, 30: 962-967.
44. Talman WT & Reis DJ (1994). Brain lesions and hypertension. In: Ganten G & de Jong W (Editors), Handbook of Hypertension: Experimental and Genetic Models of Hypertension. Vol. 19. Elsevier, Amsterdam, Holland.
45. Colombari E, Bonagamba LG & Machado BH (1994). Mechanisms of pressor and bradycardic responses to L-glutamate microinjected into the NTS of conscious rats. American Journal of Physiology, 266: R730-R738.
46. Glaum SR & Miller RJ (1993). Zinc-protoporphyrin-IX blocks the effects of metabotropic glutamate receptor activation in the rat nucleus tractus solitarii. Molecular Pharmacology, 43: 965-969.
47. Colombari E, Silva CCS, Almeida VA, Haibara AS & Johnson RA (1998). Heme oxygenase inhibitor (ZnDPG) microinjected into the nucleus tractus solitarii (NTS) affects the baroreflex and the cardiovascular responses induced by L-glutamate (L-glu) in awake rats. FASEB Journal, 12: 61(Abstract).
48. Grozdanovic Z & Gossrau R (1996). Expression of heme oxygenase-2 (HO-2)-like immunoreactivity in rat tissues. Acts Histochemica, 98: 203-214.
49. Matsuoka A, Stuehr DJ, Olson JS, Clark P & Ikeda-Saito M (1994). L-arginine and calmodulin regulation of the heme iron reactivity in neuronal nitric oxide synthase. Journal of Biological Chemistry, 269: 20335-20339.
50. Pufahl RA & Marletta MA (1993). Oxidation of NG-hydroxy-L-arginine by nitric oxide syntnase: evidence for the envolvement of the heme in catalysis. Biochemical and Biophysical Research Communications, 193: 963-970.
51. McMillan K & Masters BSS (1995). Prokaryotic expression of the heme- and flavin-binding domains of rat neuronal nitric oxide synthase as distinct polypeptides: Identification of the heme-binding proximal thiolate ligand as cysteine-415. Biochemistry, 34: 3686-3693.
52. Klatt P, Schmidt K & Mayer B (1992). Brain nitric oxide synthase is a haemoprotein. Biochemical Journal, 288: 15-17.
53. Kozma F, Johnson RA & Nasjletti A (1997). Role of carbon monoxide in heme-induced dilation. European Journal of Pharmacology, 323: R1-R2.
54. Coceani F, Kelsey L, Seidlitz E, Marks GS, McLaughlin BE, Vreman HJ, Stevenson DK, Rabinovitch M & Ackerley C (1997). Carbon monoxide formation in the ductus arteriosus in the lamb: implications for the regulation of muscle tone. British Journal of Pharmacology, 120: 599-608.
55. Suematsu M, Kashiwagi S, Sano T, Goda N, Shinoda Y & Ishimura Y (1994). Carbon monoxide as an endogenous modulator of hepatic vascular perfusion. Biochemical and Biophysical Research Communications, 205: 1333-1337.
56. Suematsu M, Goda N, Sano T, Kashiwagi S, Egawa T, Shinoda Y & Ishimura Y (1995). Carbon monoxide: an endogenous modulator of sinusoidal tone in the perfused rat liver. Journal of Clinical Investigation, 96: 2431-2437.
57. Kozma F, Ligeti L, Monos E, Colombari E & Johnson RA (1998). Heme-derived CO: Endogenous regulator of nitric oxide synthase? Pathophysiology, 5 (Suppl 1): 245 (Abstract).